Markers for the lymphatic endothelium: In search of the holy grail?

Microscopy Research and Technique

Volumn 55, Issue 2, 2001, Pages 61-69

  Sleeman, Jonathan P ^a   Krishnan, Jaya ^a   Kirkin, Vladimir ^a   Baumann, Petra ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

5 nucleotidase; Lymphatic endothelium; LYVE 1; PAL E; Podoplanin; PROX 1; VEGFR 3

Indexed keywords

BLOOD;

5′-NUCLEOTIDASE; CLINICAL UTILITY; LYMPHATIC ENDOTHELIUM; LYVE-1; MICRO-CAPILLARIES; PAL-E; PODOPLANIN; PROX-1; STRUCTURE FUNCTIONS; VEGFR-3;

CELL MEMBRANES;

5' NUCLEOTIDASE; BIOLOGICAL MARKER; CELL PROTEIN; CELL SURFACE MARKER; DESMOPLAKIN; MEMBRANE ANTIGEN; PODOPLANIN; PROTEIN LYVE 1; PROTEIN PAL E; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 3;

ACCURACY; ARTICLE; BASEMENT MEMBRANE; CELL JUNCTION; ENDOTHELIUM CELL; HISTOCHEMISTRY; HUMAN; LYMPH VESSEL ENDOTHELIUM; MICROCIRCULATION; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

EID: 0035886701     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1157     Document Type: Article

References (103)

1. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA. 1998. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95:548-553.
2. Airas L, Hellman J, Salmi M, Bono P, Puurunen T, Smith DJ, Jalkanen S. 1995. CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73. J Exp Med 182:1603-1608.
3. Allen L. 1967. Lymphatics and lymphoid tissue. Annu Rev Physiol 29:197-224.
4. Aukland K, Reed RK. 1993. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev 73:1-78.
5. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG. 1999. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144:789-801.
6. Barsky SH, Baker A, Siegal GP, Togo S, Liotta LA. 1983. Use of anti-basement membrane antibodies to distinguish blood vessel capillaries from lymphatic capillaries. Am J Surg Pathol 7:667-677.
7. Benjamin LE, Hemo I, Keshet E. 1998. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125:1591-1598.
8. Borg JP, de Lapeyriere O, Noguchi T, Rottapel R, Dubreuil P, Birnbaum D. 1995. Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase. Oncogene 10:973-984.
9. Breiteneder-Geleff S, Matsui K, Soleiman A, Meraner P, Poczewski H, Kalt R, Schaffner G, Kerjaschki D. 1997. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 151:1141-1152.
10. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K, Kerjaschki D. 1999. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154:385-394.
11. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD. 1996. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93:6025-6030.
12. Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, Breitman M, Alitalo K. 1998. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282:946-949.
13. Ebata N, Sawa Y, Ashikaga Y, Yamaoka Y, Suzuki M, Totsuka Y, Yoshida S. 1999. Lymphatic endothelium of the human tongue expresses multiple leukocyte adhesion molecules. Tissue Cell 31: 34-38.
14. Erhard H, Rietveld FJ, Brocker EB, de Waal RM, Ruiter DJ. 1996. Phenotype of normal cutaneous microvasculature Immunoelectron microscopic observations with emphasis on the differences between blood vessels and lymphatics. J Invest Dermatol 106:135-140.
15. Ezaki T, Matsuno K, Fujii H, Hayashi N, Miyakawa K, Ohmori J, Kotani M. 1990. A new approach for identification of rat lymphatic capillaries using a monoclonal antibody. Arch Histol Cytol 53:77-86.
16. Fitz LJ, Morris JC, Towler P, Long A, Burgess P, Greco R, Wang J, Gassaway R, Nickbarg E, Kovacic S, Ciarletta A, Giannotti J, Finnerty H, Zollner R, Beier DR, Leak LV, Turner KJ, Wood CR. 1997. Characterization of murine Flt4 ligand/VEGF-C. Oncogene 15:613-618.
17. Fournier E, Dubreuil P, Birnbaum D, Borg JP. 1995. Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor. Oncogene 11:921-931.
18. Fraley E, Weiss L. 1961. An electron microscopic study of the lymphatic vessels of the penile skin of the rat. Am J Anat 109:85-102.
19. Gerli R, Ibba L, Fruschelli C. 1990. A fibrillar elastic apparatus around human lymph capillaries. Anat Embryol 181:281-286.
20. Gerli R, Ibba L, Fruschelli C. 1991. Ultrastructural cytochemistry of anchoring filaments of human lymphatic capillaries and their relation to elastic fibers. Lymphology 24:105-112.
21. Gnepp DR. 1987. Vascular endothelial markers of the human thoracic duct and lacteal. Lymphology 20:36-43.
22. Guyton A, Hall J. 1996. Textbook of medical physiology, ninth ed. Philadelphia: WB Saunders.
23. Harach HR, Jasani B, Williams ED. 1983. Factor VIII as a marker of endothelial cells in follicular carcinoma of the thyroid. J Clin Pathol 36:1050-1054.
24. Harrison RL, Ewert A, Folse DS. 1986. Presence of Weibel-Palade bodies in lymphatic endothelium of the cat. Lymphology 19:170-171.
25. Heusermann U. 1979. Morphologie der LymphgefŠe, der Nerven, der Kapsel und der Trabekel der menschlichen Milz. Kiel: Medizinische Fakultaet.
26. Howat AJ, Variend S. 1985. Lymphatic invasion in Spitz nevi. Am J Surg Pathol 9:125-128.
27. Hultberg BM, Svanholm H. 1989. Immunohistochemical differentiation between lymphangiographically verified lymphatic vessels and blood vessels. Virchows Arch A Pathol Anat Histopathol 414:209-215.
28. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425 [erratum Science 1997;277:463].
29. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. 1996. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290-298 [erratum EMBO J 1996;15:1751].
30. Jussila L, Valtola R, Partanen TA, Salven P, Heikkila P, Matikainen MT, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, Alitalo K. 1998. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 58:1599-1604.
31. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VSV, Fang GH, Dumont D, Breitman M, Alitalo K. 1995. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566-3570.
32. Karnushina I, Toth I, Dux E, Joo F. 1980. Presence of the guanylate cyclase in brain capillaries: histochemical and biochemical evidence. Brain Res 189:588-592.
33. Kato S. 1990a. Histochemical localisation of 5′-nucleotidase in the lymphatic endothelium. Acta Histochem Cytochem 23:613-620.
34. Kato S. 1990b. Enzyme-histochemical identification of lymphatic vessels by light and backscattered image scanning electron microscopy. Stain Technol 65:131-137.
35. Kato S, Yasunaga A, Uchida U. 1991. Enzyme-histochemical method for identification of lymphatic capillaries. Lymphology 24:125-129.
36. Kowalczyk AP, Navarro P, Dejana E, Bornslaeger EA, Green KJ, Kopp DS, Borgwardt JE. 1998. VE-cadherin and desmoplakin are assembled into dermal microvascular endothelial intercellular junctions: a pivotal role for plakoglobin in the recruitment of desmoplakin to intercellular junctions. J Cell Sci 111:3045-3057.
37. Kubo H, Fujiwara T, Jussila L, Hashi H, Ogawa M, Shimizu K, Awane M, Sakai Y, Takabayashi A, Alitalo K, Yamaoka Y, Nishikawa SI. 2000. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 96:546-553.
38. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, Alitalo K. 1996. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122:3829-3837.
39. Laurent T. 1998. The chemistry, biology and medical applications of hyaluronan and its derivatives. London: Portland Press.
40. Leak L, Burke J. 1966. Fine structure of the lymphatic capillary and the adjoining connective tissue area. Am J Anat 118:785-810.
41. Leak L, Burke J. 1968. Ultrastructural studies on the lymphatic anchoring filaments. J Cell Biol 36:129-149.
42. Lee J, Gray A, Yuan J, Luoh SM, Avraham H, Wood WI. 1996. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA 93:1988-1992.
43. Leenstra S, Troost D, Das PK, Claessen N, Becker AE, Bosch DA. 1993. Endothelial cell marker PAL-E reactivity in brain tumor, developing brain, and brain disease. Cancer 72:3061-3067.
44. Little D, Said JW, Siegel RJ, Fealy M, Fishbein MC. 1986. Endothelial cell markers in vascular neoplasms: an immunohistochemical study comparing factor VIII-related antigen, blood group specific antigens, 6-keto-PGF1 alpha, and Ulex europaeus 1 lectin. J Pathol 149:89-95.
45. Lymboussaki A, Partanen TA, Olofsson B, Thomas-Crusells J, Fletcher CD, de Waal RM, Kaipainen A, Alitalo K. 1998. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol 153:395-403.
46. Madri J, Sankar S, Romanic A. 1996. Angiogenesis. In: Clark RAF, editor. The molecular and cellular biology of wound repair, 2nd ed. New York: Plenum Press. p 355-371.
47. Magari S, Ito Y. 1988. Weibel-Palade bodies in endothelial cells of normal thoracic ducts and deep cervical lymphatics in rabbits. Lymphology 21:93-98.
48. Magari S, Ito Y, Sakanaka M. 1989. An immunoelectron microscopic study of von Willebrand factor in the thoracic duct endothelium of rats. Lymphology 22:76-80.
49. Marchetti C, Poggi P, Calligaro A, Casasco A. 1992. Lymphatic vessels of the human dental pulp in different conditions. Anat Rec 234:27-33.
50. Matsui K, Breiteneder-Geleff S, Kerjaschki D. 1998. Epitope-specific antibodies to the 43-kD glomerular membrane protein podoplanin cause proteinuria and rapid flattening of podocytes. J Am Soc Nephrol 9:2013-2026.
51. Matsui K, Breitender-Geleff S, Soleiman A, Kowalski H, Kerjaschk D. 1999. Podoplanin, a novel 43-kDa membrane protein, controls the shape of podocytes. Nephrol Dial Transpl 14:9-11.
52. Miettinen M, Lindenmayer AE, Chaubal A. 1994. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens-evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 7:82-90.
53. Mukai K, Rosai J, Burgdorf WH. 1980. Localization of factor VIII-related antigen in vascular endothelial cells using an immunoperoxidase method. Am J Surg Pathol 4:273-276.
54. Mustonen T, Alitalo K 1995. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129:895-898.
55. Nadimi H, Saatee S, Armin A, Toto PD. 1988. Expression of endothelial cell markers PAL-E and EN-4 and Ia-antigens in Kaposi's sarcoma. J Oral Pathol 17:416-420.
56. Nagle RB, Witte MH, Martinez AP, Witte CL, Hendrix MJ, Way D, Reed K. 1987. Factor VIII-associated antigen in human lymphatic endothelium. Lymphology 20:20-24.
57. Nerlich AG, Schleicher E. 1991. Identification of lymph and blood capillaries by immunohistochemical staining for various basement membrane components. Histochemistry 96:449-453.
58. Nishida S, Ohkuma M. 1992. Enzyme-histochemical identification of the human lymphatic capillary by adenylate cyclase. Lymphology 25:184-190.
59. Nishida S, Ohkuma M. 1993. Enzyme-histochemical staining of dermal lymphatic capillaries by guanylate cyclase. Lymphology 26: 195-199.
60. Nose K, Saito H, Kuroki T. 1990. Isolation of a gene sequence induced later by tumor-promoting 12-O-tetradecanoylphorbol-13-acetate in mouse osteoblastic cells (MC3T3-E1) and expressed constitutively in ras-transformed cells. Cell Growth Differ 1:511-518.
61. Oh SJ, Jeltsch MM, Birkenhäger R, McCarthy JE, Weich HA, Christ B, Alitalo K, Wilting J. 1997. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188:96-109.
62. Ordonez NG, Brooks T, Thompson S, Batsakis JG. 1987. Use of Ulex europaeus agglutinin I in the identification of lymphatic and blood vessel invasion in previously stained microscopic slides. Am J Surg Pathol 11:543-550.
63. Otsuki Y, Kubo H, Magari S. 1990. Immunohistochemical differentiation between lymphatic vessels and blood vessels - use of anti-basement membrane antibodies and anti-factor VIII-related antigen. Arch Histol Cytol 53:95-105.
64. Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K. 2000. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156:1499-1504.
65. Pajusola K, Aprelikova O, Armstrong E, Morris S, Alitalo K. 1993. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts. Oncogene 8:2931-2937.
66. Paku S, Paweletz N. 1991. First steps of tumor-related angiogenesis. Lab Invest 65:334-346.
67. Partanen TA, Alitalo K, Miettinen M. 1999. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 86:2406-2412.
68. Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, Stacker SA, Achen MG, Alitalo K. 2000. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues [In Process Citation]. FASEB J 14:2087-2096.
69. Poggi P, Casasco A, Marchetti C, Casasco M, Cornaglia A, Calligaro A, Lethias C, Hartmann DJ. 1995. Ultrastructural Localization of elastin-like immunoreactivity in the extracellular matrix around human small lymphatic vessels. Lymphology 28:189-195.
70. Rishi AK, Joyce-Brady M, Fisher J, Dobbs LG, Floros J, VanderSpek J, Brody JS, Williams MC. 1995. Cloning, characterization, and development expression of a rat lung alveolar type I cell gene in embryonic endodermal and neural derivatives. Dev Biol 167:294-306.
71. Ruiter DJ, Schlingemann RO, Westphal JR, Denijn M, Rietveld FJ, De Waal RM. 1993. Angiogenesis in wound healing and tumor metastasis. Behring Inst Mitt 258-272.
72. Ryan TJ. 1989. Structure and function of lymphatics. J Invest Dermatol 93:18S-24S.
73. Sakariassen KS, Bolhuis PA, Sixma JJ. 1979. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature 279:636-638.
74. Sauter B, Foedinger D, Sterniczky B, Wolff K, Rappersberger K. 1998. Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytochem 46:165-176.
75. Sawa Y, Mukaida A, Suzuki M, Yoshida S. 1997. Identification of lymphatic vessels by using a monoclonal antibody specific for the human thoracic duct. Microvasc Res 53:142-149.
76. Sawa Y, Yamaoka Y, Ebata N, Ashikaga Y, Kim T, Suzuki M, Yoshida S. 1999a. Immunohistochemical study on leukocyte adhesion molecules expressed on lymphatic endothelium. Microvasc Res 57:292-297.
77. Sawa Y, Shibata K, Braithwaite MW, Suzuki M, Yoshida S. 1999b. Expression of immunoglobulin superfamily members on the lymphatic endothelium of inflamed human small intestine. Microvasc Res 57:100-106.
78. Schlingemann RO, Dingjan GM, Emeis JJ, Blok J, Warnaar SO, Ruiter DJ. 1985. Monoclonal antibody PAL-E specific for endothelium. Lab Invest 52:71-76.
79. Schlingemann RO, Hofman P, Anderson L, Troost D, van der Gaag R. 1997. Vascular expression of endothelial antigen PAL-E indicates absence of blood-ocular barriers in the normal eye. Ophthalmic Res 29:130-138.
80. Schmelz M, Franke WW. 1993. Complexus adhaerentes, a new group of desmoplakin-containing junctions in endothelial cells: the syndesmos connecting retrothelial cells of lymph nodes. Eur J Cell Biol 61:274-289.
81. Schmelz M, Moll R, Kuhn C, Franke WW. 1994. Complexus adhaerentes, a new group of desmoplakin-containing junctions in endothelial cells: II Different types of lymphatic vessels. Differentiation 57:97-117.
82. Schmitt GM, Schmidt SP. 1986. The effects of different fixatives for immunofluorescent and immunoperoxidase localization of factor VIII-related antigen in canine carotid artery and vascular prostheses. Histochem J 18:351-356.
83. Schnyder-Candrian S, Borsig L, Moser R, Berger EG. 2000. Localization of alpha 1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells. Proc Natl Acad Sci USA 97:8369-8374.
84. Sehested M, Hou-Jensen K. 1981. Factor VIII-related antigen as an endothelial cell marker in benign and malignant diseases. Virchows Arch [Pathol Anat] 391:217-225.
85. Svanholm H, Nielsen K, Hauge P. 1984. Factor VIII-related antigen and lymphatic collecting vessels. Virchows Arch A Pathol Anat Histopathol 404:224-228.
86. Taipale J, Makinen T, Arighi E, Kukk E, Karkkainen M, Alitalo K. 1999. Vascular endothelial growth factor receptor-3. Curr Top Microbiol Immunol 237:85-96.
87. Thompson LF, Ruedi JM, Glass A, Low MG, Lucas AH. 1989. Antibodies to 5′-nucleotidase (CD73), a glycosyl-phosphatidylinositol-anchored protein, cause human peripheral blood T cells to proliferate. J Immunol 143:1815-1821.
88. Thomson LF, Ruedi JM, Glass A, Moldenhauer G, Moller P, Low MG, Klemens MR, Massaia M, Lucas AH. 1990. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73). Tissue Antigens 35:9-19.
89. Valiron O, Chevrier V, Usson Y, Breviario F, Job D, Dejana E. 1996. Desmoplakin expression and organization at human umbilical vein endothelial cell-to-cell junctions. J Cell Sci 109:2141-2149.
90. Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, Pihlajaniemi T, Weich HA, deWaal R, Alitalo K. 1999. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154:1381-1390.
91. Vetter W. 1970. Alkalische Phosphatasen in Mastzellen, Blut- und Lymphgefäßen der Rattenzunge: 5′-nucleotidase-, unspezifische alkalische Phosphatase- und Polyphosphatase-(ATP′ase) Aktivität unter besondere Berucksichtigung des pH. Z Anat Entwickl-Gesch 130:153-176.
92. Vorbrodt AW, Szumanska G, Dobrogowska DH. 1984. Cytochemical studies of adenylate cyclase in the choroid plexus and brain vessels of rat and mouse. J Histochem Cytochem 32:275-284.
93. Wagner DD, Olmsted JB, Marder VJ. 1982. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol 95:355-360.
94. Walker RA. 1985. Ulex europeus I - peroxidase as a marker of vascular endothelium: its application in routine histopathology. J Pathol 146:123-127.
95. Weber E, Lorenzoni P, Lozzi G, Sacchi G. 1994. Cytochemical differentiation between blood and lymphatic endothelium: bovine blood and lymphatic large vessels and endothelial cells in culture. J Histochem Cytochem 42:1109-1115.
96. Weninger W, Partanen TA, Breiteneder-Geleff S, Mayor C, Kowalski H, Mildner M, Pammer J, Sturzl M, Kerjaschki D, Alitalo K, Tschachler E. 1999. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest 79:243-251.
97. Werner JA, Schünke M, Tillmann B. 1987. Histochemical visualization of lymphatic capillaries in the rat: a comparison of methods demonstrated at the posterior pharyngeal surface. Arch Histol Jpn 50:505-514.
98. Wetterwald A, Hoffstetter W, Cecchini MG, Lanske B, Wagner C, Fleisch H, Atkinson M. 1996. Characterization and cloning of the Ell antigen, a marker expressed by rat osteoblasts and osteocytes. Bone 18:125-132.
99. Wigle JT, Oliver G. 1999. Prox1 function is required for the development of the murine lymphatic system. Cell 98:769-778.
100. Wilkinson LS, Edwards JC. 1991. Demonstration of lymphatics in human synovial tissue. Rheumatol Int 11:151-155.
101. Yoshizawa M, Shingaki S, Nakajima T, Saku T. 1994. Histopathological study of lymphatic invasion in squamous cell carcinoma (O-1N) with high potential of lymph node metastasis. Clin Exp Metastasis 12:347-356.
102. Zimmermann H. 1992. 5′-Nucleotidase: molecular structure and functional aspects. Biochem J 285:345-365.
103. Zoellner HF, Hunter N. 1989. Histochemical identification of the vascular endothelial isoenzyme of alkaline phosphatase. J Histochem Cytochem 37:1893-1898.